Regulatory UK MHRA authorises orforglipron private prescription PharmaphorumEli Lilly has announced that orforglipron (Foundayo) is now available to be prescribed for eligible adults via private prescription.Metabolic & GLP-1Read full story pharminent August 24, 2026 (Last updated: September 1, 2026) Pharmaphorum Eli Lilly has announced that orforglipron (Foundayo) is now available to be prescribed for eligible adults via private prescription. Metabolic & GLP-1 Read full story Post navigation Previous: Johnson & Johnson Wins EU Approval for Tecvayli-Daratumumab in Second-Line MyelomaNext: Johnson & Johnson’s multiple myeloma treatment secures EC approval Related Stories Regulatory FDA clears Takeda, Protagonist’s first-in-class PV drug pharminent August 31, 2026 Regulatory FDA green lights Priovant drug for rare skin disease pharminent August 28, 2026 Regulatory Neurocrine receives FDA IND Acceptance for Alzheimer’s Ph2 pharminent August 26, 2026
